Crinetics Pharmaceuticals (CRNX) Other Non-Current Assets (2017 - 2026)

Crinetics Pharmaceuticals' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $800000.0 for Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 38.46% year-over-year to $800000.0 in Q1 2026; TTM through Mar 2026 was $800000.0, a 38.46% decrease from a year earlier, with the FY2025 full-year figure at $22.3 million, up 689.22% from the prior year.
• Other Non-Current Assets eased to $800000.0 in Q1 2026 per CRNX's latest filing, from $22.3 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $22.3 million in Q4 2025 and bottomed at $500000.0 in Q1 2022.
• The 5-year median for Other Non-Current Assets is $1.3 million (2022), against an average of $2.6 million.
• Across the five-year window, Other Non-Current Assets surged 689.22% in 2025 and slumped 38.46% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $1.3 million in 2022, then changed by 0.0% to $1.3 million in 2023, then jumped by 117.62% to $2.8 million in 2024, then jumped by 689.22% to $22.3 million in 2025, then slumped by 96.42% to $800000.0 in 2026.
• Per Business Quant, the three latest CRNX Other Non-Current Assets figures stand at $800000.0 (Q1 2026), $22.3 million (Q4 2025), and $1.3 million (Q3 2025).